Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6838
Title: | Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study | Authors: | Atallah, Natalie J Panossian, Vahe S Atallah, Christine J Schwabe, Andrej Johannes, Sascha Wiemer, Jan Mansour, Michael K |
Affiliations: | Faculty of Medicine | Keywords: | COVID-19 ICU MR-proADM Biomarkers; viral pneumonia |
Issue Date: | 2022-08-24 | Part of: | Open Forum Infectious Diseases | Volume: | 9 | Issue: | 9 | Abstract: | Mid-regional proadrenomedullin (MR-proADM) is a biomarker released following endothelial damage. Studies have shown a correlation in predicting coronavirus disease 2019 (COVID-19) outcomes with MR-proADM levels. Our study aimed to investigate baseline MR-proADM as a predictor of a wider range of clinical outcomes of varying severity in patients admitted with COVID-19, and to compare to other biomarkers. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/6838 | ISSN: | 2328-8957 | DOI: | 10.1093/ofid/ofac423 | Ezproxy URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.